Herpesvirus BACs: Past, Present, and Future

Overview

Journal J Biomed Biotechnol

Specialty Biology

Date 2010 Nov 5

PMID 21048927

Citations 34

Authors

Charles Warden

Qiyi Tang

Hua Zhu

Affiliations

Soon will be listed here.

Abstract

The herpesviridae are a large family of DNA viruses with large and complicated genomes. Genetic manipulation and the generation of recombinant viruses have been extremely difficult. However, herpesvirus bacterial artificial chromosomes (BACs) that were developed approximately 10 years ago have become useful and powerful genetic tools for generating recombinant viruses to study the biology and pathogenesis of herpesviruses. For example, BAC-directed deletion mutants are commonly used to determine the function and essentiality of viral genes. In this paper, we discuss the creation of herpesvirus BACs, functional analyses of herpesvirus mutants, and future applications for studies of herpesviruses. We describe commonly used methods to create and mutate herpesvirus BACs (such as site-directed mutagenesis and transposon mutagenesis). We also evaluate the potential future uses of viral BACs, including vaccine development and gene therapy.

Citing Articles

The emerging role of recombineering in microbiology.

Li R, Li A, Zhang Y, Fu J Eng Microbiol. 2024; 3(3):100097.

PMID: 39628926 PMC: 11610958. DOI: 10.1016/j.engmic.2023.100097.

Development and immunogenicity evaluation of a quadruple-gene-deleted pseudorabies virus strain.

Li H, Zhang R, Qu J, Kang Y, Zhang J, Guo R Front Microbiol. 2024; 15:1479794.

PMID: 39372271 PMC: 11449858. DOI: 10.3389/fmicb.2024.1479794.

Structure-guided mutagenesis targeting interactions between pp150 tegument protein and small capsid protein identify five lethal and two live-attenuated HCMV mutants.

Stevens A, Cruz-Cosme R, Armstrong N, Tang Q, Zhou Z Virology. 2024; 596:110115.

PMID: 38805802 PMC: 11260070. DOI: 10.1016/j.virol.2024.110115.

Herpes Simplex Virus ICP27 Protein Inhibits AIM 2-Dependent Inflammasome Influencing Pro-Inflammatory Cytokines Release in Human Pigment Epithelial Cells (hTert-RPE 1).

Caproni A, Nordi C, Fontana R, Facchini M, Melija S, Pappada M Int J Mol Sci. 2024; 25(9).

PMID: 38731826 PMC: 11083950. DOI: 10.3390/ijms25094608.

Oncolytic varicella-zoster virus engineered with ORF8 deletion and armed with drug-controllable interleukin-12.

Jiang H, Nace R, Carrasco T, Zhang L, Peng K, Russell S J Immunother Cancer. 2024; 12(3).

PMID: 38527762 PMC: 10966791. DOI: 10.1136/jitc-2023-008307.

References

Goodman L, Loregian A, Perkins G, Nugent J, Buckles E, Mercorelli B . A point mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog. 2007; 3(11):e160. PMC: 2065875. DOI: 10.1371/journal.ppat.0030160. View

Schmeisser F, Weir J . Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes. BMC Biotechnol. 2007; 7:22. PMC: 1885250. DOI: 10.1186/1472-6750-7-22. View

Adler H, Messerle M, Wagner M, Koszinowski U . Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol. 2000; 74(15):6964-74. PMC: 112213. DOI: 10.1128/jvi.74.15.6964-6974.2000. View

Schleiss M, Stroup G, Pogorzelski K, McGregor A . Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine. Vaccine. 2006; 24(37-39):6175-86. DOI: 10.1016/j.vaccine.2006.06.077. View

Ali A, Saito S, Shibata S, Takada K, Kanda T . Distinctive effects of the Epstein-Barr virus family of repeats on viral latent gene promoter activity and B-lymphocyte transformation. J Virol. 2009; 83(18):9163-74. PMC: 2738248. DOI: 10.1128/JVI.01979-08. View

Hansen S, Powers C, Richards R, Ventura A, Ford J, Siess D . Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science. 2010; 328(5974):102-6. PMC: 2883175. DOI: 10.1126/science.1185350. View

Cicin-Sain L, Brune W, Bubic I, Jonjic S, Koszinowski U . Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo. J Virol. 2003; 77(15):8249-55. PMC: 165264. DOI: 10.1128/jvi.77.15.8249-8255.2003. View

Hahn G, Rose D, Wagner M, Rhiel S, McVoy M . Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique. Virology. 2003; 307(1):164-77. DOI: 10.1016/s0042-6822(02)00061-2. View

Brune W, Menard C, Hobom U, Odenbreit S, Messerle M, Koszinowski U . Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis. Nat Biotechnol. 1999; 17(4):360-4. DOI: 10.1038/7914. View

10.

Schumacher D, Tischer B, Fuchs W, Osterrieder N . Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J Virol. 2000; 74(23):11088-98. PMC: 113189. DOI: 10.1128/jvi.74.23.11088-11098.2000. View

11.

Rosas C, Konig P, Beer M, Dubovi E, Tischer B, Osterrieder N . Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. J Gen Virol. 2007; 88(Pt 3):748-757. DOI: 10.1099/vir.0.82528-0. View

12.

Shizuya H, Birren B, Kim U, Mancino V, Slepak T, Tachiiri Y . Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc Natl Acad Sci U S A. 1992; 89(18):8794-7. PMC: 50007. DOI: 10.1073/pnas.89.18.8794. View

13.

Niizuma T, Zerboni L, Sommer M, Ito H, Hinchliffe S, Arvin A . Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J Virol. 2003; 77(10):6062-5. PMC: 154042. DOI: 10.1128/jvi.77.10.6062-6065.2003. View

14.

Xu Y, Rodriguez-Huete A, Pari G . Evaluation of the lytic origins of replication of Kaposi's sarcoma-associated virus/human herpesvirus 8 in the context of the viral genome. J Virol. 2006; 80(19):9905-9. PMC: 1617234. DOI: 10.1128/JVI.01004-06. View

15.

Meseda C, Schmeisser F, Pedersen R, Woerner A, Weir J . DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome. Virology. 2004; 318(1):420-8. PMC: 7173264. DOI: 10.1016/j.virol.2003.09.033. View

16.

Pavlova I, Virgin 4th H, Speck S . Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication. J Virol. 2003; 77(10):5731-9. PMC: 154050. DOI: 10.1128/jvi.77.10.5731-5739.2003. View

17.

Saeki Y, Ichikawa T, Saeki A, Chiocca E, Tobler K, Ackermann M . Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther. 1999; 9(18):2787-94. DOI: 10.1089/hum.1998.9.18-2787. View

18.

Kahrs A, Odenbreit S, Schmitt W, Heuermann D, Meyer T, Haas R . An improved TnMax mini-transposon system suitable for sequencing, shuttle mutagenesis and gene fusions. Gene. 1995; 167(1-2):53-7. DOI: 10.1016/0378-1119(95)00671-0. View

19.

Ahsan N, Kanda T, Nagashima K, Takada K . Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. J Virol. 2005; 79(7):4415-24. PMC: 1061545. DOI: 10.1128/JVI.79.7.4415-4424.2005. View

20.

Calderwood M, White R, Griffiths R, Whitehouse A . Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence. J Gen Virol. 2005; 86(Pt 10):2703-2708. DOI: 10.1099/vir.0.81230-0. View